258 related articles for article (PubMed ID: 37059911)
1. Advances in Vaccine Adjuvants: Nanomaterials and Small Molecules.
Sun B; Li M; Yao Z; Yu G; Ma Y
Handb Exp Pharmacol; 2024; 284():113-132. PubMed ID: 37059911
[TBL] [Abstract][Full Text] [Related]
2. Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity.
Shi S; Zhu H; Xia X; Liang Z; Ma X; Sun B
Vaccine; 2019 May; 37(24):3167-3178. PubMed ID: 31047671
[TBL] [Abstract][Full Text] [Related]
3. Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity.
Marciani DJ
Drug Discov Today; 2003 Oct; 8(20):934-43. PubMed ID: 14554157
[TBL] [Abstract][Full Text] [Related]
4. Vaccine Adjuvants: Selection Criteria, Mechanism of Action Associated with Immune Responses and Future Directions.
Habib A; Anjum KM; Iqbal R; Jaffar G; Ashraf Z; Khalid MS; Taj MU; Zainab SW; Umair M; Zohaib M; Khalid T
Iran J Immunol; 2023 Mar; 20(1):1-15. PubMed ID: 36917475
[TBL] [Abstract][Full Text] [Related]
5. Vaccine adjuvants to engage the cross-presentation pathway.
Lee W; Suresh M
Front Immunol; 2022; 13():940047. PubMed ID: 35979365
[TBL] [Abstract][Full Text] [Related]
6. Vaccine adjuvants: mechanisms and platforms.
Zhao T; Cai Y; Jiang Y; He X; Wei Y; Yu Y; Tian X
Signal Transduct Target Ther; 2023 Jul; 8(1):283. PubMed ID: 37468460
[TBL] [Abstract][Full Text] [Related]
7. TLR9 and STING agonists cooperatively boost the immune response to SARS-CoV-2 RBD vaccine through an increased germinal center B cell response and reshaped T helper responses.
Yang JX; Tseng JC; Tien CF; Lee CY; Liu YL; Lin JJ; Tsai PJ; Liao HC; Liu SJ; Su YW; Hsu LC; Chen JK; Huang MH; Yu GY; Chuang TH
Int J Biol Sci; 2023; 19(9):2897-2913. PubMed ID: 37324951
[TBL] [Abstract][Full Text] [Related]
8. Rational design of polymer-based particulate vaccine adjuvants.
Huete-Carrasco J; Lynch RI; Ward RW; Lavelle EC
Eur J Immunol; 2024 Feb; 54(2):e2350512. PubMed ID: 37994660
[TBL] [Abstract][Full Text] [Related]
9. An Overview of Novel Adjuvants Designed for Improving Vaccine Efficacy.
Bonam SR; Partidos CD; Halmuthur SKM; Muller S
Trends Pharmacol Sci; 2017 Sep; 38(9):771-793. PubMed ID: 28668223
[TBL] [Abstract][Full Text] [Related]
10. Applications of nanomaterials as vaccine adjuvants.
Zhu M; Wang R; Nie G
Hum Vaccin Immunother; 2014; 10(9):2761-74. PubMed ID: 25483497
[TBL] [Abstract][Full Text] [Related]
11. Improved immune responses and safety of foot-and-mouth disease vaccine containing immunostimulating components in pigs.
Choi JH; You SH; Ko MK; Jo HE; Shin SH; Jo H; Lee MJ; Kim SM; Kim B; Lee JS; Park JH
J Vet Sci; 2020 Sep; 21(5):e74. PubMed ID: 33016020
[TBL] [Abstract][Full Text] [Related]
12. Trends in vaccine adjuvants.
Schijns VE; Lavelle EC
Expert Rev Vaccines; 2011 Apr; 10(4):539-50. PubMed ID: 21506650
[TBL] [Abstract][Full Text] [Related]
13. Vaccine adjuvants: Tailoring innate recognition to send the right message.
Lavelle EC; McEntee CP
Immunity; 2024 Apr; 57(4):772-789. PubMed ID: 38599170
[TBL] [Abstract][Full Text] [Related]
14. Modulating potency: Physicochemical characteristics are a determining factor of TLR4-agonist nanosuspension activity.
Dowling QM; Sivananthan SJ; Guderian JA; Moutaftsi M; Chesko JD; Fox CB; Vedvick TS; Kramer RM
J Pharm Sci; 2014 Mar; 103(3):879-89. PubMed ID: 24464844
[TBL] [Abstract][Full Text] [Related]
15. In-depth review of delivery carriers associated with vaccine adjuvants: current status and future perspectives.
Zeng Y; Zou F; Xia N; Li S
Expert Rev Vaccines; 2023; 22(1):681-695. PubMed ID: 37496496
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in self-adjuvanting glycoconjugate vaccines.
Manabe Y; Chang TC; Fukase K
Drug Discov Today Technol; 2020 Dec; 37():61-71. PubMed ID: 34895656
[TBL] [Abstract][Full Text] [Related]
17. Nucleic acids presenting polymer nanomaterials as vaccine adjuvants.
Comberlato A; Paloja K; Bastings MMC
J Mater Chem B; 2019 Nov; 7(41):6321-6346. PubMed ID: 31460563
[TBL] [Abstract][Full Text] [Related]
18. Developments in Vaccine Adjuvants.
Firdaus FZ; Skwarczynski M; Toth I
Methods Mol Biol; 2022; 2412():145-178. PubMed ID: 34918245
[TBL] [Abstract][Full Text] [Related]
19. The Preparation and Physicochemical Characterization of Aluminum Hydroxide/TLR7a, a Novel Vaccine Adjuvant Comprising a Small Molecule Adsorbed to Aluminum Hydroxide.
Malyala P; Laera D; Cianetti S; Bufali S; Aggravi M; Ianni E; Judge C; Otten G; Singh M; O'Hagan DT
J Pharm Sci; 2018 Jun; 107(6):1577-1585. PubMed ID: 29421216
[TBL] [Abstract][Full Text] [Related]
20. Vaccines with aluminum-containing adjuvants: optimizing vaccine efficacy and thermal stability.
Clapp T; Siebert P; Chen D; Jones Braun L
J Pharm Sci; 2011 Feb; 100(2):388-401. PubMed ID: 20740674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
